Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
Primary Purpose
Hearing Loss, Dizziness, Vertigo
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hearing aids equipped with motion sensing abilities
Sponsored by
About this trial
This is an interventional screening trial for Hearing Loss
Eligibility Criteria
Inclusion Criteria:
- Age 55 years or older
- Bilateral hearing aid user
- Able to consent in English
- Having access to a phone capable of running the mobile app required for the study
- Screen for fall risk ("Yes" to any question: Feels unsteady when standing or walking? Worries about falling? Has fallen in past year? If the participant has fallen: how many times? were they injured/hurt?)
- Ambulatory without need for a wheelchair
Exclusion Criteria:
- People with mobility restrictions (e.g., wheelchair bound) that would prevent the performance of the functional assessments.
- People with severe movement (e.g., Advanced Parkinson's disease) or cognitive (e.g., advanced dementia) disorders that would prevent the individual from either performing the functional assessments, or would lead to restricted activities that would prevent motion data from being collected according to the goal of the study.
- Inability to understand, consent, and complete requirements including verbal instructions and non-ambulatory/wheelchair-dependent.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Participants
Arm Description
Participants will wear study hearing aids that are equipped with embedded sensors and artificial intelligence. This will help track their movement and signal if the participant falls or is at fall risk.
Outcomes
Primary Outcome Measures
Fall risk assessment using CDC's STEADI protocol
Participants will undergo the Centers for Disease Control and Prevention (CDC)'s STEADI (Stopping Elderly Accidents, Deaths & Injuries) fall risk assessment with the hearing aids on. The scoring for these tests will be done by the tester, 2 independent raters, and the hearing aids. A comparison of the fall risk assessments by the testers and the hearing aids is the primary outcome measure.
Secondary Outcome Measures
Full Information
NCT ID
NCT05365646
First Posted
April 26, 2022
Last Updated
May 3, 2022
Sponsor
Stanford University
Collaborators
Starkey Laboratories, Inc
1. Study Identification
Unique Protocol Identification Number
NCT05365646
Brief Title
Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
Official Title
Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 2022 (Anticipated)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
May 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
Starkey Laboratories, Inc
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to develop and validate methods to use hearing aids equipped with embedded sensors and artificial intelligence to assist in the assessment of fall risk and in the implementation of interventions aimed at reducing the risk of falling, as well as to improve speech intelligibility in quiet and in background noise, track physical activity, and social engagement. The investigators hope is that the knowledge that is generated through this study will ultimately translate to the clinical setting and will help reduce the likelihood that individuals experience a fall, and improve the quality of hearing in individuals who wear hearing aids.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hearing Loss, Dizziness, Vertigo
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
250 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Participants
Arm Type
Experimental
Arm Description
Participants will wear study hearing aids that are equipped with embedded sensors and artificial intelligence. This will help track their movement and signal if the participant falls or is at fall risk.
Intervention Type
Device
Intervention Name(s)
Hearing aids equipped with motion sensing abilities
Intervention Description
Participants will wear hearing aids that will assess their movement, and fall risk.
Primary Outcome Measure Information:
Title
Fall risk assessment using CDC's STEADI protocol
Description
Participants will undergo the Centers for Disease Control and Prevention (CDC)'s STEADI (Stopping Elderly Accidents, Deaths & Injuries) fall risk assessment with the hearing aids on. The scoring for these tests will be done by the tester, 2 independent raters, and the hearing aids. A comparison of the fall risk assessments by the testers and the hearing aids is the primary outcome measure.
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age 55 years or older
Bilateral hearing aid user
Able to consent in English
Having access to a phone capable of running the mobile app required for the study
Screen for fall risk ("Yes" to any question: Feels unsteady when standing or walking? Worries about falling? Has fallen in past year? If the participant has fallen: how many times? were they injured/hurt?)
Ambulatory without need for a wheelchair
Exclusion Criteria:
People with mobility restrictions (e.g., wheelchair bound) that would prevent the performance of the functional assessments.
People with severe movement (e.g., Advanced Parkinson's disease) or cognitive (e.g., advanced dementia) disorders that would prevent the individual from either performing the functional assessments, or would lead to restricted activities that would prevent motion data from being collected according to the goal of the study.
Inability to understand, consent, and complete requirements including verbal instructions and non-ambulatory/wheelchair-dependent.
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33284647
Citation
Rahme M, Folkeard P, Scollie S. Evaluating the Accuracy of Step Tracking and Fall Detection in the Starkey Livio Artificial Intelligence Hearing Aids: A Pilot Study. Am J Audiol. 2021 Mar 10;30(1):182-189. doi: 10.1044/2020_AJA-20-00105. Epub 2020 Dec 7.
Results Reference
background
PubMed Identifier
31914373
Citation
Burwinkel JR, Xu B, Crukley J. Preliminary Examination of the Accuracy of a Fall Detection Device Embedded into Hearing Instruments. J Am Acad Audiol. 2020 Jun;31(6):393-403. doi: 10.3766/jaaa.19056. Epub 2020 Aug 3.
Results Reference
background
Learn more about this trial
Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
We'll reach out to this number within 24 hrs